Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …

2024年3月13日 · Objective Multimorbidity is defined as the co-occurrence of at least two chronic conditions in the same individual. Multimorbidity can have an impact on patient´s quality of life, …

2024年7月27日 · Objective To obtain updated estimates on the incidence and prevalence of systemic lupus erythematosus (SLE) in the UK, over the period 1990–2020, using the Clinical …

A lupus journal publishing basic, clinical, translational and epidemiological studies on all aspects of lupus and related diseases. An official journal of Lupus Foundation of America.

2024年9月4日 · Immune dysregulation in systemic lupus erythematosus (SLE) results in the autoimmune manifestations of SLE, but also leads to an impaired immune response to …

The paradigm of drug approval in SLE currently relies on successful large phase III randomised controlled trials and a set of primary, secondary and additional end points. Taken together, …

2024年5月22日 · Our 2022 published working definition of disease modification in systemic lupus erythematosus (SLE) was ‘minimising disease activity with the fewest treatment-associated …

2022年9月26日 · Purpose Activation of toll-like receptor (TLR)7/8 by self-RNA induces production of type I interferon and several other proinflammatory cytokines, which may contribute to the …

2024年9月5日 · Hemophagocytic lymphohistiocytosis (HLH) is a well-recognised complication of systemic lupus erythematosus (SLE). In one small case series, HLH was noted in …

Nordmann-GomesfiA, etfial Lupus Science Medicine 202411:e001331 doi:101136lupus-2024-001331 1 Lupus nephritis randomised controlled trials: evidence gaps and under- represented …